Tough comps, supply disruption and the ever-present pricing pressure impacts growth

SmartTRAK reports that the WW Trauma Market experienced a downturn in Q3, posting only +1.1% (reported) growth. The US Market was up +2.0% YoY, but is down sequentially compared to last quarter’s +5.0% gains...

Among the many topics covered in SmartTRAK's Q318 Trauma Market Recap are:

US market experiences slight softening as the top four trauma players all post sequential declines in Q218

The WW Trauma Market was up in Q218 – the third consecutive quarter of growth in the +4% range. Internationally, positive sales growth in Europe offset a sequential slowdown in Rest of World (ROW). In Europe, revenues were steady, while ROW sales dipped sequentially as the top players reported softer growth due to tough comps as a result of 2017 tender orders...

Among the many topics covered Q218 Trauma Market Recap are:

SmartTRAK is excited to be attending AOFAS 2018 - American Orthopaedic Foot & Ankle Society - on July 11-14, 2018 in Boston, Massachusetts.

Representing SmartTRAK will be Natasha Weeks, Sr. Analyst, Trauma & Extremities Fixation, Christopher McCarthy, VP Corporate Accounts, Orthopedics and Neuro and Michelle Calderon, Account Manager, Orthopedics. Please contact us if you would like a meeting!

SmartTRAK's  Trauma & Extremities Fixations Sr. Analyst Natasha Weeks identified several key product trends at the Orthopaedic Trauma Association’s (OTA) 33rd Annual Meeting in Vancouver, BC Oct. 11-14, 2017, as manufacturers looked to differentiate themselves and gain share in the US Trauma market, projected to reach over $2.2B by 2021. 

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its Q118 Trauma Market Recap.

SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its  2017 Trauma Market Recap and  Financial Dashboard.

Despite slightly tougher US comps in Q4, the Trauma Market ended 2017 with steady, mid-single-digit growth primarily driven from the IM Nailing segment. The strength of the IM Nailing segment has been a multi-year story as a result of trauma market leader DePuy Synthes’ TFNA Nail boosting sales each quarter. Other players such as Smith & Nephew and Zimmer Biomet have followed suit touting their own hip and femur nails as growth drivers during the quarter ...

Q317 Trauma Market Recap: Emerging Products, Players Boost the Market

New products and players, along with healthy international sales, gave the Trauma Market a boost in Q317.

By Natasha Weeks, Managing Editor/Sr. Analyst Trauma & Extremities

Strong US growth supported by healthy international sales helped propel the WW Trauma Market up in Q317 – the second quarter with growth. Despite more difficult comps, the trauma segment continued to post yet another quarter of steady growth. IM Nailing, the segment powerhouse, led the charge while Plates & Screws followed suit.